Particle.news
Download on the App Store

France Unveils 2026–2030 Obesity Roadmap, Pledging Reimbursed Care and a Reinforced 2026 Treatment Pathway

It focuses on earlier detection through funded multidisciplinary support, leaving drug reimbursement undecided.

le gouvernement a dévoilé sa feuille de route 2026-2030 pour la prise en charge de l'obésité, sans trancher sur le remboursement des médicaments

Overview

  • The Health Ministry’s plan commits to reimbursing dietetic, psychological and adapted physical-activity consultations and to expanding professional training.
  • A reinforced, coordinated care and therapeutic education pathway for adults with complex or severe obesity will be deployed in 2026 after earlier trials.
  • Authorities cite rising prevalence—about 18% of adults in 2024—and persistent regional and socio-economic gaps, with rates highest in Hauts-de-France and overseas territories.
  • France now counts 42 specialized obesity centers, including five added since 2025, with further territorial strengthening and local care pathways planned.
  • Reimbursement for new anti-obesity drugs remains under negotiation despite favorable health authority opinions that envisage strict prescribing criteria.